Beactica: More Efficient Resonance

Surface plasmon resonance, or SPR, is used in fragment-based drug discovery because it provides a wealth of information about how a compound or fragment interacts with its target. Beactica AB is seeking to improve the interpretation of that information, and subsequently the optimization of leads, with an add-on to GE Healthcare's

Read the full 511 word article

User Sign In